This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Hereditary Liability To Pressure Palsies
Information about Hereditary Liability To Pressure Palsies: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Hereditary Liability To Pressure Palsies
Most recent studies have shown that Hereditary Liability To Pressure Palsies shares some biological mechanisms with charcot-marie-tooth-disease, charcot-marie-tooth-disease-type-ia-(disorder), dejerine-sottas-disease-(disorder), demyelinating-diseases, demyelinating-polyneuropathy, demyelination, hereditary-motor-and-sensory-neuropathies, hereditary-sensory-and-autonomic-neuropathies, inherited-neuropathy, mononeuropathies, muscular-atrophy, nerve-compression-syndrome, nervous-system-disorder, nervousness, neuralgic-amyotrophy, peripheral-neuropathy, polyneuropathy, sensory-neuropathy, weakness.
Among the many pathways, these few ones have gauged particular interests from scientists studying Hereditary Liability To Pressure Palsies, and have been seen in publications frequently: Aging, Cell Adhesion, Cell Cycle, Cell Proliferation, Cell-cell Adhesion, Double-strand Break Repair, Gene Conversion, Hypersensitivity, Interphase, Localization, Meiosis, Muscle Atrophy, Myelin Maintenance, Myelination, Pathogenesis, Reflex, Regeneration, Schwann Cell Proliferation, Translation, Transposition
Quite a number of genes have been found to play important roles in Hereditary Liability To Pressure Palsies, such as ALB, AR, EGR2, ENDOU, EXOSC6, GDI1, GJB1, KIF1B, MAD2L1BP, MAG, MB, MFN2, MPZ, NR0B1, PMP22, PXMP2, RPLP0, S100A10. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.